Code | 6496D | ||||||||||
MA number | EU/1/20/1504/001 | ||||||||||
Product Form: | con inf 1x1 ml/1 mg (liek.inj.skl.) | ||||||||||
MA Status: | Ev - Valid centralised marketing authorisation under exceptional circumstances | ||||||||||
Type of procedure: | EU Orphan | ||||||||||
MAH, country: | Stemline Therapeutics B.V., Netherland | ||||||||||
Therapeutic Class: | 44 - CYTOSTATICA | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 36 | ||||||||||
Container: | glass vial | ||||||||||
Route of admin.: | Intravenous use |
Prescription Status: | Medicinal product subject to restricted medical prescription. |
Legal basis: | Article 8(3) application - new active substance |
MA issued: | 07.01.2021 |
Validity: | 07.01.2026 |
SmPC + PL: | European Medicines Agency's database |
Safety feature | Yes |
Data update: | 03.11.2022 |